Jorge Santos da Silva
2021
In 2021, Jorge Santos da Silva earned a total compensation of $5.1M as Chief Executive Officer at MoonLake Immunotherapeutics.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $11,043 |
|---|---|
| Salary | $230,143 |
| Stock Awards | $4,840,290 |
| Total | $5,081,476 |
Silva received $4.8M in stock awards, accounting for 95% of the total pay in 2021.
Silva also received $11K of change in pension value and nonqualified deferred compensation earnings and $230.1K in salary.
Rankings
In 2021, Jorge Santos da Silva's compensation ranked 2,572nd out of 12,406 executives tracked by ExecPay. In other words, Silva earned more than 79.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,572 out of 12,406 | 79th |
Division Manufacturing | 1,022 out of 5,494 | 81st |
Major group Chemicals And Allied Products | 395 out of 2,369 | 83rd |
Industry group Drugs | 346 out of 2,090 | 83rd |
Industry Pharmaceutical Preparations | 226 out of 1,537 | 85th |
Source: SEC filing on April 26, 2023.
Silva's colleagues
We found two more compensation records of executives who worked with Jorge Santos da Silva at MoonLake Immunotherapeutics in 2021.